Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;16(1):93-100.
doi: 10.2450/2017.0119-16. Epub 2017 Jan 30.

Molecular basis of the Duffy blood group system

Affiliations
Review

Molecular basis of the Duffy blood group system

Gabriela Höher et al. Blood Transfus. 2018 Jan.

Abstract

ACKR1, located on chromosome 1q23.2, is the gene that encodes a glycoprotein expressing the Duffy blood group antigens. This gene is transcribed in two mRNA variants yielding two isoforms, encoding proteins with 338 and 336 amino acids. This review provides a general overview of the Duffy blood group to characterise and elucidate the genetic basis of this system. The Fya and Fyb antigens are encoded by co-dominant FY*A (FY*01) and FY*B (FY*02) alleles, which differ by c.125G>A (rs12075), defining the Fy(a+b-), Fy(a-b+) and Fy(a+b+) phenotypes. The Fy(a-b-) phenotype that occurs in Africans provides an explanation for the apparent absence of Plasmodium vivax in this region: this phenotype arises from homozygosity for the FY*B allele carrying a point mutation c.1-67T>C (rs2814778), which prevents Fyb antigen expression only in red blood cells. The same mutation has also been found on the FY*A allele, but it is very rare. The Fy(a-b-) phenotype in Europeans and Asians arises from mutations in the coding region of the FY*A or FY*B allele, preventing Duffy antigen expression on any cell in the body and thus are true Duffy null phenotypes. According to the International Society for Blood Transfusion, ten alleles are associated with the null expression of the Fy antigens. Furthermore, different allelic forms of FY*B modify Fyb antigen expression, which may result in very weak or equivocal serology results. The mostly common found variants, c.265C>T (rs34599082) and c.298G>A (rs13962) -previously defined in combination only with the FY*B allele - have already been observed in the FY*A allele. Thus, six alleles have been recognised and associated with weak expression of the Fy antigens. Considering the importance of the Duffy blood group system in clinical medicine, additional studies via molecular biology approaches must be performed to resolve and clarify the discrepant results that are present in the erythrocyte phenotyping.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
ACKR1 gene structure and proteins and mRNA isoforms. Viewing the figure from top to bottom: the black box represents the ACKR1 gene, the white box shows the mRNA of isoform B (NM_002036.3) and the dashed box shows the isoform B protein (NP_002027.2); the next white box represents the mRNA of isoform A (NM_001122951.2) and the dashed box shows the protein of isoform A (NP_001116423.1). The arrows indicate the positions of the main genetic variants already described

References

    1. Issitt PD, Anstee DJ. Applied Blood Group Serology. 4th edition. Durham, NC: Montgomery Scientific Publications; 1998.
    1. Storry JR, Castilho L, Chen Q, et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and terminology: report of the Seoul and London meetings. ISBT Science Series. 2016;11:118–22. - PMC - PubMed
    1. Reid ME, Yazdanbakhsh K. Molecular insights into blood groups and implications for blood transfusion. Curr Opin Hematol. 1998;5:93–102. - PubMed
    1. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007;21:58–71. - PubMed
    1. Coles SM, Klein HG, Holland PV. Alloimmunization in two multitransfused patient populations. Transfusion. 1981;21:462–6. - PubMed

Substances

LinkOut - more resources